| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 43.394 | 86.715 | 76.872 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 43.394 | 86.716 | 76.872 |
| Total Expenses - EUR | - | - | - | - | - | - | 5.744 | 55.836 | 86.672 | 89.673 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -5.744 | -12.441 | 44 | -12.801 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -5.744 | -12.882 | -850 | -14.051 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Helleborus Pharmaceutical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 3.791 | 6.477 | 23.439 | 18.194 |
| Current Assets | - | - | - | - | - | - | 643 | 18.711 | 22.107 | 23.820 |
| Inventories | - | - | - | - | - | - | 0 | 12.561 | 16.746 | 17.834 |
| Receivables | - | - | - | - | - | - | 0 | 6.098 | 4.834 | 4.363 |
| Cash | - | - | - | - | - | - | 643 | 52 | 527 | 1.624 |
| Shareholders Funds | - | - | - | - | - | - | -5.703 | -18.604 | -19.397 | -33.340 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 10.137 | 43.792 | 64.943 | 75.354 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Helleborus Pharmaceutical S.r.l.